PayPay Securities Corp »

Crispr Therapeutics shares owned by PayPay Securities Corp

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by PayPay Securities Corp from 13F filings

Historical chart of PayPay Securities Corp investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by PayPay Securities Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by PayPay Securities Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2k 18 68.17
2023-12-31 $1.3k 21 62.90
2023-09-30 $6.0k 16 377.38
2023-06-30 $841 15 56.13
2023-03-31 $813 18 45.22
2022-12-31 $1.8k 45 40.64